Peak health, cable multi-measures and actively respond to power rationing.
Release time:
2022-08-24
Since July this year, high temperature weather has continued in many parts of our country, and power consumption and power load are also growing rapidly, requiring people to use electricity in an orderly manner. According to the unified arrangement of the superior, starting from the beginning of September
, Bailongqiao Power Supply Institute will limit the power supply to the factories within its jurisdiction. The power supply will be low at7 to at night, and the power supply will be normal at night. Located in Linjiang Industrial Park, peak health, peak cable 2 enterprises actively respond to the policy, strictly implement the relevant scheduling instructions. Due to the abnormal climate, this year's power limit is larger than in previous years, and the start time is earlier. In previous years, the general starting time of power rationing in summer is 9 and 10
. A scheduled power supply schedule will be given and a few days will be arranged to stop for a few days. This year, starting in late7 and early 8 , the electricity consumption time of the next day will be temporarily notified on the same day. The notification time is uncertain, the power consumption time is uncertain, and there may be changes in the middle, which will have a certain impact on the production arrangement. Zhao Chunquan, assistant to the general manager of Jianfeng Health, said that the given electricity consumption after power rationing is barely enough for production. In order to fully guarantee production, all electrical equipment is classified into grades to ensure the demand for production of key equipment, safety and environmental protection equipment. Not critical equipment, such as laboratory equipment, office air conditioning all stop using. Arrange someone to keep an eye on the meter and adjust it immediately if the limit is exceeded. Guo Zhijian, manager of the production department of Cable Company, said that the given power consumption after power restriction is only enough for a small number of low-power machines to use. Key processes such as making sheaths in cable production require stability, and once interrupted, great losses will be caused. In the face of difficulties, the cable company adjusted the shift and put the key process into night production. Adjust the sales strategy and production plan, and actively communicate with customers to cancel or postpone some orders to minimize losses. During the night shift, in order to ensure production safety and product quality, middle-level cadres take turns on duty and arrange supper for night shift workers. During the extraordinary period, employees also expressed their understanding and support, and various work arrangements were carried out in an orderly manner.
(Reporter
Chen Shengmu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page